关键词：心脏生物标记物；指标；可测量物质；诊断及危险分层与心血管病
摘 要：A cardiac biomarker is defined as a measurable substance that is used as an indicator for diagnosis and risk stratification related to CVDs such as ACS, coronary syndromes, MI, and HF. Some of the cardiac biomarkers are CK-MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, HFABP, LDH isoenzymes, D-Dimer, IMA, MPO, myoglobin, and sCD40L. Cardiac biomarker assays help medical professionals in understanding and differentiating between MI and angina, which assists in the diagnosis and treatment of CVDs. The abnormal concentration of these biomarkers will act as a significant predictor of an adverse cardiovascular condition. Cardiac POC testing offers reliable measurement of cardiac biomarkers and provides results within an hour. Some cardiac POC tests not only save time, but have also been modified to improve the accuracy of the measurement of enzymes and minimize errors.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Type of Assay

08. Global Troponin Assay Market

08.1 Introduction

08.2 Market Overview

08.3 Market Size and Forecast

09. Global BNP and NT-proBNP Assay Market

09.1 Introduction

09.2 Market Overview

09.3 Market Size and Forecast

10. Global CK-MB Assay Market

10.1 Introduction

10.2 Market Size and Forecast

11. Global Myoglobin Assay Market

11.1 Introduction

11.2 Market Size and Forecast

12. Market Segmentation by End-users

12.1 Global Cardiac Biomarkers Market

Segmentation by End-users

12.2 Global Cardiac POC Testing Market

12.2.1 Introduction

12.2.2 Market Overview

12.2.3 Market Size and Forecast

12.2.4 Geographical Segmentation

12.3 Global Troponin Market in POC Setting

12.3.1 Market Overview

12.3.2 Market Size and Forecast

12.4 Global BNP and NT-proBNP Market in POC

Setting

12.4.1 Market Overview

12.4.2 Market Size and Forecast

13. Global Cardiac Laboratory Testing Market

13.1.1 Introduction

13.1.2 Market Overview

13.1.3 Market Size and Forecast

13.1.4 Geographical Segmentation

13.2 Global Troponin Market in Laboratory Setting

13.2.1 Market Overview

13.2.2 Market Size and Forecast

13.3 Global BNP and NT-proBNP Market in Laboratory

Setting

13.3.1 Market Overview

13.3.2 Market Size and Forecast

14. Geographical Segmentation

14.1 Cardiac Biomarkers Market in Americas

14.1.1 Market Size and Forecast

14.2 Cardiac Biomarkers Market in US

14.3 Cardiac Biomarkers Market in EMEA Region

14.4 Cardiac Biomarkers Market in Europe

14.5 Cardiac Biomarkers Market in APAC Region

14.6 Cardiac Biomarkers Market in China

15. Key Leading Countries

15.1 US

15.2 China

16. Buying Criteria

17. Market Growth Drivers

18. Drivers and their Impact

19. Market Challenges

20. Impact of Drivers and Challenges

21. Market Trends

22. Trends and their Impact

23. Vendor Landscape

23.1 Competitive Scenario

23.1.1 Key News

23.1.2 Mergers and Acquisitions

23.2 Market Share Analysis 2013

23.3 Other Prominent Vendors

24. Key Vendor Analysis

24.1 Abbott Laboratories

24.1.1 Key Facts

24.1.2 Business Overview

24.1.3 Business Segmentation by Revenue 4

24.1.4 Business Segmentation by Revenue 2011 and 2012

24.1.5 Geographical Segmentation by Revenue

24.1.6 Business Strategy

24.1.7 Key Information

24.1.8 SWOT Analysis

24.2 Alere

24.2.1 Key Facts

24.2.2 Business Overview

24.2.3 Business Segmentation by Revenue 2013

24.2.4 Business Segmentation by Revenue 2012 and 2013

24.2.5 Geographical Segmentation by Revenue 2013

24.2.6 Business Strategy

24.2.7 Recent Developments

24.2.8 SWOT Analysis

24.3 Ortho-Clinical Diagnostics

24.3.1 Key Facts

24.3.2 Business Overview

24.3.3 Key Developments

24.3.4 SWOT Analysis

24.4 Roche Diagnostics

24.4.1 Key Facts

24.4.2 Business Overview

24.4.3 Business Segmentation by Revenue 2013

24.4.4 Geographical Segmentation by Revenue 2013

25.1.2 Business Strategy

25.1.3 Recent Developments

25.1.4 SWOT Analysis

25.Other Reports in this Series